Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 509

1.

Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout.

Bursill D, Taylor WJ, Terkeltaub R, Abhishek A, So AK, Vargas-Santos AB, Gaffo AL, Rosenthal A, Tausche AK, Reginato A, Manger B, Sciré C, Pineda C, van Durme C, Lin CT, Yin C, Albert DA, Biernat-Kaluza E, Roddy E, Pascual E, Becce F, Perez-Ruiz F, Sivera F, Lioté F, Schett G, Nuki G, Filippou G, McCarthy G, da Rocha Castelar Pinheiro G, Ea HK, Tupinambá HA, Yamanaka H, Choi HK, Mackay J, ODell JR, Vázquez Mellado J, Singh JA, Fitzgerald JD, Jacobsson LTH, Joosten L, Harrold LR, Stamp L, Andrés M, Gutierrez M, Kuwabara M, Dehlin M, Janssen M, Doherty M, Hershfield MS, Pillinger M, Edwards NL, Schlesinger N, Kumar N, Slot O, Ottaviani S, Richette P, MacMullan PA, Chapman PT, Lipsky PE, Robinson P, Khanna PP, Gancheva RN, Grainger R, Johnson RJ, Te Kampe R, Keenan RT, Tedeschi SK, Kim S, Choi SJ, Fields TR, Bardin T, Uhlig T, Jansen T, Merriman T, Pascart T, Neogi T, Klück V, Louthrenoo W, Dalbeth N.

Ann Rheum Dis. 2019 Sep 9. pii: annrheumdis-2019-215933. doi: 10.1136/annrheumdis-2019-215933. [Epub ahead of print]

PMID:
31501138
2.

Systemic sclerosis is associated with knee arthroplasty outcomes: a National US study.

Singh JA, Cleveland JD.

Clin Rheumatol. 2019 Aug 23. doi: 10.1007/s10067-019-04754-4. [Epub ahead of print]

PMID:
31444650
3.

Factors Influencing the Effectiveness of Allopurinol in Achieving and Sustaining Target Serum Urate in the National Veterans Administration Gout Cohort.

Singh JA, Yang S, Saag KG.

J Rheumatol. 2019 Aug 15. pii: jrheum.190522. doi: 10.3899/jrheum.190522. [Epub ahead of print]

PMID:
31416925
4.

Are the days of missed or delayed diagnosis of gout over?

Singh JA.

Nat Rev Rheumatol. 2019 Aug 12. doi: 10.1038/s41584-019-0286-7. [Epub ahead of print] No abstract available.

PMID:
31406335
5.

Correction to: Gout and healthcare utilization and complications after hip arthroplasty: a cohort study using the US National Inpatient Sample (NIS).

Singh JA, Cleveland JD.

Clin Rheumatol. 2019 Sep;38(9):2651-2653. doi: 10.1007/s10067-019-04709-9.

PMID:
31359295
6.

Informed consent and community engagement in open field research: lessons for gene drive science.

Singh JA.

BMC Med Ethics. 2019 Jul 27;20(1):54. doi: 10.1186/s12910-019-0389-3.

7.

Filgotinib, a JAK1 Inhibitor, for Treatment-Resistant Rheumatoid Arthritis.

Singh JA.

JAMA. 2019 Jul 23;322(4):309-311. doi: 10.1001/jama.2019.9056. No abstract available.

PMID:
31334773
8.

Persistent organic pollutants (POPs) increase rage signaling to promote downstream cardiovascular remodeling.

Coole JB, Burr SS, Kay AM, Singh JA, Kondakala S, Yang EJ, Kaplan BLF, Howell GE 3rd, Stewart JA Jr.

Environ Toxicol. 2019 Oct;34(10):1149-1159. doi: 10.1002/tox.22817. Epub 2019 Jul 16.

PMID:
31313498
9.
10.

Is there a role for cherries in the management of gout?

Collins MW, Saag KG, Singh JA.

Ther Adv Musculoskelet Dis. 2019 May 17;11:1759720X19847018. doi: 10.1177/1759720X19847018. eCollection 2019. Review.

11.

Insurance Payer type and Income are associated with outcomes after total shoulder arthroplasty.

Singh JA, Cleveland JD.

J Rheumatol. 2019 Jun 1. pii: jrheum.190287. doi: 10.3899/jrheum.190287. [Epub ahead of print]

PMID:
31154417
12.

Total knee arthroplasty outcomes in lupus: a study using the US National Inpatient Sample.

Singh JA, Cleveland JD.

Rheumatology (Oxford). 2019 May 23. pii: kez176. doi: 10.1093/rheumatology/kez176. [Epub ahead of print]

PMID:
31121046
13.

Lupus is associated with poorer outcomes after primary total hip arthroplasty.

Singh JA, Cleveland JD.

Lupus. 2019 Jun;28(7):834-842. doi: 10.1177/0961203319851573. Epub 2019 May 22. Erratum in: Lupus. 2019 Sep;28(10):1281.

PMID:
31117886
14.

Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial.

Singh JA, Fraenkel L, Green C, Alarcón GS, Barton JL, Saag KG, Hanrahan LM, Raymond SC, Kimberly RP, Leong AL, Reyes E, Street RL Jr, Suarez-Almazor ME, Eakin GS, Marrow L, Morgan CJ, Caro B, Sloan JA, Jandali B, Garcia SR, Grossman J, Winthrop KL, Trupin L, Dall'Era M, Meara A, Rizvi T, Chatham WW, Yazdany J.

PLoS Med. 2019 May 8;16(5):e1002800. doi: 10.1371/journal.pmed.1002800. eCollection 2019 May.

15.

Guidance on stakeholder engagement practices to inform the development of area-wide vector control methods.

Thizy D, Emerson C, Gibbs J, Hartley S, Kapiriri L, Lavery J, Lunshof J, Ramsey J, Shapiro J, Singh JA, Toe LP, Coche I, Robinson B.

PLoS Negl Trop Dis. 2019 Apr 25;13(4):e0007286. doi: 10.1371/journal.pntd.0007286. eCollection 2019 Apr. No abstract available.

16.

Rates of Total Joint Replacement in the United States: Future Projections to 2020-2040 Using the National Inpatient Sample.

Singh JA, Yu S, Chen L, Cleveland JD.

J Rheumatol. 2019 Sep;46(9):1134-1140. doi: 10.3899/jrheum.170990. Epub 2019 Apr 15.

PMID:
30988126
17.
18.

Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018.

Chiarotto A, Kaiser U, Choy E, Christensen R, Conaghan PG, Cowern M, Gill M, de Wit M, Gargon E, Horgan B, Kirkham JJ, Simon LS, Singh JA, Tugwell P, Turk DC, Mease PJ.

J Rheumatol. 2019 Apr 1. pii: jrheum.181099. doi: 10.3899/jrheum.181099. [Epub ahead of print]

PMID:
30936284
19.

Gout and chronic pain in older adults: a Medicare claims study.

Singh JA, Cleveland JD.

Clin Rheumatol. 2019 Jul;38(7):1953-1960. doi: 10.1007/s10067-019-04526-0. Epub 2019 Mar 29.

PMID:
30927116
20.
21.

World Health Organization Guidance on Ethical Considerations in Planning and Reviewing Research Studies on Sexual and Reproductive Health in Adolescents.

Singh JA, Siddiqi M, Parameshwar P, Chandra-Mouli V.

J Adolesc Health. 2019 Apr;64(4):427-429. doi: 10.1016/j.jadohealth.2019.01.008. No abstract available.

22.

Gout and sexual function: patient perspective of how gout affects personal relationships and intimacy.

Singh JA.

BMC Rheumatol. 2019 Feb 28;3:8. doi: 10.1186/s41927-019-0056-9. eCollection 2019.

23.
24.

Patient-Centered Outcomes and Key Study Procedure Finalization in the Pilot Feasibility Gout Randomized Trial: Comparative Feasibility Study in GOUt, CHerry Extract Versus Diet Modification (Mini-GOUCH).

Singh JA, Willig AL, Darnell B, Green C, Morgan S, Weiss R, Saag KG, Cutter G, McGwin G.

J Clin Rheumatol. 2019 Mar 12. doi: 10.1097/RHU.0000000000001018. [Epub ahead of print]

PMID:
30870252
25.

Cardiovascular Disease in Gout and the Protective Effect of Treatments Including Urate-Lowering Therapy.

Gupta MK, Singh JA.

Drugs. 2019 Apr;79(5):531-541. doi: 10.1007/s40265-019-01081-5. Review.

PMID:
30868398
26.

Characterization of patients with chronic refractory gout who do and do not have clinically apparent tophi and their response to pegloticase.

Lawrence Edwards N, Singh JA, Troum O, Yeo AE, Lipsky PE.

Rheumatology (Oxford). 2019 Mar 6. pii: kez017. doi: 10.1093/rheumatology/kez017. [Epub ahead of print]

PMID:
30843588
27.

OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies.

Boers M, Beaton DE, Shea BJ, Maxwell LJ, Bartlett SJ, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March L, Simon LS, Singh JA, Strand V, Wells GA, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1021-1027. doi: 10.3899/jrheum.181096. Epub 2019 Feb 15.

PMID:
30770515
28.

Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology.

Maxwell LJ, Beaton DE, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit M, Gossec L, March L, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1014-1020. doi: 10.3899/jrheum.181097. Epub 2019 Feb 15.

PMID:
30770502
29.

The risk of Sjogren's syndrome in the older adults with gout: A medicare claims study.

Singh JA, Cleveland JD.

Joint Bone Spine. 2019 Feb 7. pii: S1297-319X(19)30019-3. doi: 10.1016/j.jbspin.2019.01.022. [Epub ahead of print]

PMID:
30738190
30.

Gout is associated with increased healthcare utilization after knee arthroplasty.

Singh JA, Cleveland JD.

Ann Rheum Dis. 2019 Aug;78(8):1146-1148. doi: 10.1136/annrheumdis-2018-214934. Epub 2019 Feb 2. No abstract available. Erratum in: Ann Rheum Dis. 2019 Sep;78(9):e102.

PMID:
30712016
31.

OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions.

Toupin-April K, Barton JL, Fraenkel L, Meara A, Li LC, Brooks P, de Wit M, Stacey D, Légaré F, Shea B, Lyddiatt A, Hofstetter C, Christensen R, Scholte Voshaar M, Suarez-Almazor ME, Boonen A, Meade T, March L, Jull JE, Campbell W, Alten R, Karuranga S, Morgan EM, Kelly A, Kaufman J, Hill S, Maxwell LJ, Beaton D, El-Miedany Y, Mittoo S, Bartlett SJ, Singh JA, Tugwell PS.

J Rheumatol. 2019 Feb 1. pii: jrheum.181071. doi: 10.3899/jrheum.181071. [Epub ahead of print]

PMID:
30709963
32.

Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology.

Beaton DE, Maxwell LJ, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March LM, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1028-1035. doi: 10.3899/jrheum.181218. Epub 2019 Feb 1.

PMID:
30709952
33.

A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout.

Singh JA, Green C, Morgan S, Willig AL, Darnell B, Saag KG, Weiss R, Cutter G, McGwin G.

J Clin Rheumatol. 2019 Jan 23. doi: 10.1097/RHU.0000000000001004. [Epub ahead of print]

PMID:
30702450
34.
35.

Gout and healthcare utilization and complications after hip arthroplasty: a cohort study using the US National Inpatient Sample (NIS).

Singh JA, Cleveland JD.

Clin Rheumatol. 2019 Apr;38(4):1213-1216. doi: 10.1007/s10067-019-04434-3. Epub 2019 Jan 22. Erratum in: Clin Rheumatol. 2019 Jul 29;:.

PMID:
30671748
36.

Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials.

Andersen KM, Cheah JTL, March L, Bartlett SJ, Beaton D, Bingham CO 3rd, Brooks PM, Christensen R, Conaghan PG, D'Agostino MA, de Wit M, Dueck AC, Goodman SM, Grosskleg S, Hill CL, Howell M, Mackie SL, Richards B, Shea B, Singh JA, Strand V, Tugwell P, Wells GA, Simon LS.

J Rheumatol. 2019 Aug;46(8):1053-1058. doi: 10.3899/jrheum.181123. Epub 2019 Jan 15.

PMID:
30647191
37.

The Third Biennial 2018 OMERACT First-time Participant Program: A Qualitative and Quantitative Study.

Sloan VS, Grosskleg S, Wells G, Singh JA.

J Rheumatol. 2019 Aug;46(8):1036-1040. doi: 10.3899/jrheum.181196. Epub 2019 Jan 15.

PMID:
30647187
38.

Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative.

Nielsen SM, Tugwell P, de Wit MPT, Boers M, Beaton DE, Woodworth TG, Escorpizo R, Shea B, Toupin-April K, Guillemin F, Strand V, Singh JA, Kloppenburg M, Furst DE, Wells GA, Smolen JS, Veselý R, Boonen A, Storgaard H, Voshaar M, March L, Christensen R; Contextual Factors Working Group.

J Rheumatol. 2019 Sep;46(9):1159-1163. doi: 10.3899/jrheum.181081. Epub 2019 Jan 15.

PMID:
30647174
39.

Addressing Challenges in Developing a Core Domain Set in Adherence Interventions in Rheumatology: A Report from the OMERACT-Adherence Group.

Kelly A, Bartlett SJ, de Wit MP, Beaton DE, Dawson T, Evans V, Gill M, Hassett G, March L, Scholte-Voshaar M, Singh JA, Tong A, Tugwell P, Wong P, Tymms K.

J Rheumatol. 2019 Sep;46(9):1202-1206. doi: 10.3899/jrheum.181078. Epub 2019 Jan 15.

PMID:
30647162
40.

Patient Perceptions of Gout Management Goals: A Cross-sectional Internet Survey.

Singh JA, Edwards NL.

J Clin Rheumatol. 2019 Jan 4. doi: 10.1097/RHU.0000000000000981. [Epub ahead of print]

PMID:
30614892
41.

Gout and the risk of Parkinson's disease in older adults: a study of U.S. Medicare data.

Singh JA, Cleveland JD.

BMC Neurol. 2019 Jan 5;19(1):4. doi: 10.1186/s12883-018-1234-x.

42.

Patient perspectives in gout: a review.

Singh JA.

Curr Opin Rheumatol. 2019 Mar;31(2):159-166. doi: 10.1097/BOR.0000000000000583.

PMID:
30575598
43.

Gout and the risk of incident depression in older adults.

Singh JA, Cleveland JD.

Psychiatry Res. 2018 Dec;270:842-844. doi: 10.1016/j.psychres.2018.10.067. Epub 2018 Oct 30.

PMID:
30551333
44.

Effectiveness of healthcare educational and behavioral interventions to improve gout outcomes: a systematic review and meta-analysis.

Ramsubeik K, Ramrattan LA, Kaeley GS, Singh JA.

Ther Adv Musculoskelet Dis. 2018 Nov 19;10(12):235-252. doi: 10.1177/1759720X18807117. eCollection 2018 Dec. Review.

45.

Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.

Singh JA, Guyatt G, Ogdie A, Gladman DD, Deal C, Deodhar A, Dubreuil M, Dunham J, Husni ME, Kenny S, Kwan-Morley J, Lin J, Marchetta P, Mease PJ, Merola JF, Miner J, Ritchlin CT, Siaton B, Smith BJ, Van Voorhees AS, Jonsson AH, Shah AA, Sullivan N, Turgunbaev M, Coates LC, Gottlieb A, Magrey M, Nowell WB, Orbai AM, Reddy SM, Scher JU, Siegel E, Siegel M, Walsh JA, Turner AS, Reston J.

Arthritis Care Res (Hoboken). 2019 Jan;71(1):2-29. doi: 10.1002/acr.23789. Epub 2018 Nov 30.

PMID:
30499259
46.

Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.

Singh JA, Guyatt G, Ogdie A, Gladman DD, Deal C, Deodhar A, Dubreuil M, Dunham J, Husni ME, Kenny S, Kwan-Morley J, Lin J, Marchetta P, Mease PJ, Merola JF, Miner J, Ritchlin CT, Siaton B, Smith BJ, Van Voorhees AS, Jonsson AH, Shah AA, Sullivan N, Turgunbaev M, Coates LC, Gottlieb A, Magrey M, Nowell WB, Orbai AM, Reddy SM, Scher JU, Siegel E, Siegel M, Walsh JA, Turner AS, Reston J.

Arthritis Rheumatol. 2019 Jan;71(1):5-32. doi: 10.1002/art.40726. Epub 2018 Nov 30.

PMID:
30499246
47.

Challenges of Practicing Rheumatology in a Government Setting: A County Hospital and Veterans Affairs Hospital Perspective.

Miller GD, Singh JA.

Rheum Dis Clin North Am. 2019 Feb;45(1):39-51. doi: 10.1016/j.rdc.2018.09.004. Review.

PMID:
30447745
48.

Gout and dementia in the elderly: a cohort study of Medicare claims.

Singh JA, Cleveland JD.

BMC Geriatr. 2018 Nov 14;18(1):281. doi: 10.1186/s12877-018-0975-0.

49.

In situ observation of phase changes of a silica-supported cobalt catalyst for the Fischer-Tropsch process by the development of a synchrotron-compatible in situ/operando powder X-ray diffraction cell.

Hoffman AS, Singh JA, Bent SF, Bare SR.

J Synchrotron Radiat. 2018 Nov 1;25(Pt 6):1673-1682. doi: 10.1107/S1600577518013942. Epub 2018 Oct 26.

PMID:
30407177
50.

Tapering Janus kinase inhibitors in rheumatoid arthritis with low disease activity or remission: reality or dream?

Singh JA.

Ann Rheum Dis. 2019 Feb;78(2):153-154. doi: 10.1136/annrheumdis-2018-213694. Epub 2018 Oct 9. No abstract available.

PMID:
30301716

Supplemental Content

Loading ...
Support Center